Abstract 2037P
Background
Prehabilitation is a process that aims to improve a patient's functional capacity before surgery. It may reduce postoperative complications and improve outcomes in cancer patients, particularly those frail. However, the effectiveness of prehabilitation in frail cancer patients undergoing elective surgery is not well understood. This systematic review and meta-analysis aimed to evaluate prehabilitation's effects on postoperative outcomes in frail cancer patients undergoing elective surgery.
Methods
Our search included electronic databases such as PubMed, Embase, and Cochrane and was conducted until January 2022. We had studies that compared a prehabilitation or preoperative optimization program to standard care, postoperative rehabilitation, or a placebo. The primary outcomes of interest were postoperative complications, length of hospital stay, 30-day mortality, and hospital readmission rate. We used R version 4.0.3 and the metafor and meta packages for statistical analysis.
Results
A total of 8 studies met the inclusion criteria for the meta-analysis, with 581 patients in the prehabilitation group and 675 patients in the control group. The results showed that prehabilitation was associated with a significant reduction in postoperative complications (risk ratio (RR) 0.83, 95% confidence interval (CI) 0.69 to 0.98). Prehabilitation was also associated with a significant reduction in length of hospital stay (mean difference -2.32 days, 95% CI -4.34 to -0.29) and a non-significant reduction in 30-day mortality (RR 0.45, 95% CI 0.13 to 1.59). There was no significant difference in hospital readmission rate between the prehabilitation and control groups (RR 1.09, 95% CI 0.38 to 3.15).
Conclusions
Prehabilitation may improve hospital stay and reduce postoperative complications in frail cancer patients undergoing elective surgery. Further research is needed to confirm these findings and determine rehabilitation interventions' optimal duration and intensity. Clinicians need to consider the potential benefits of prehabilitation in caring for frail cancer patients preparing for surgery.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06
2095P - Cancer rehabilitation program for cancer-related fatigue
Presenter: Aizhan Bekisheva
Session: Poster session 06